HALOZYME THERAPEUTICS INC. - US40637H1095 (Aktie)
Nasdaq
| Kurs | Diff.% | Datum & Zeit | Bid Volumen | Bid | Ask | Ask Volumen |
|---|---|---|---|---|---|---|
60,08 USD
|
1,7443% | 30.07.2025 22:00 | 100,00 | 59,00 | 61,69 | 200,00 |
| Kontakt | |
|---|---|
|
Halozyme Therapeutics Inc. Sorrento Valley Road 92121, San Diego, CA, US |
| Telefon | +1 858 794 8889 |
| Fax | +1 858 704 8311 |
| info@halozyme.com | |
| Internet | http://www.halozyme.com |
| IR Kontakt/PR Kontakt | -/- |
| Symbol | |
| Ende des Geschäftsjahres | 31.12.2025 |
| Marktkapitalisierung | 6.299.792.212,89 EUR |
| Anteilseigner |
|---|
| Vorstand | |
|---|---|
| Jeffrey Henderson | Chairman of Board of Directors |
| Akiko Miyashita | Member of Board of Directors |
| Barbara Duncan | Member of Board of Directors |
| Connie Matsui | Member of Board of Directors |
| Matthew Posard | Member of Board of Directors |
| Dr. Jean Bizzari | Member of Board of Directors |
| Bernadette Connaughton | Member of Board of Directors |
| Unternehmensprofil |
|---|
| - |
© 2000 - 2025 UniCredit Bank Austria AG. Bitte beachten Sie die Nutzungsbedingungen
Daten und Kursinformationen von FactSet
Fondsdaten von Mountain-View Data Gmbh
Austria-HomePage Version 2.0.54
